Search filters

List of works by Alberto J Lorenzatti

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

scientific article published on 29 March 2009

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

scientific article published on 27 August 2017

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein

scientific article published on 24 October 2007

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

scientific article published on 17 March 2017

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prev

scientific article published on 22 September 2009

Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial ⬇️

scientific article published on June 12, 2011

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial

scientific article published on 02 April 2019

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial

scientific article published on 14 April 2019

Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial

scientific article published on 21 September 2018

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

scientific article published on 28 March 2009

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction

scientific article published on 04 June 2019

Paulina is supported by:

About Paulina

Help